发明名称 TARGETING THE REVERSE MODE OF THE Na+/Ca2+ EXCHANGER FOR THE TREATMENT OF OPTIC NEUROPATHY ASSOCIATED WITH GLAUCOMA AND ISCHEMIC OPTIC NEUROPATHY
摘要 <p>A method for preventing retinal ganglion cell depth, associated with glaucoma, in an animal of the mammalian species, including humans, comprising the step of administering to ganglion cells and their axons (optic nerve) of said mammal a pharmaceutical composition which comprises as its active ingredient one or more compounds having activity for blocking a reverse mode of the sodium/calcium exchanger.</p>
申请公布号 WO2003039573(A1) 申请公布日期 2003.05.15
申请号 US2002032651 申请日期 2002.10.11
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址